Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$5.86
-4.1%
$6.17
$4.05
$9.87
$160.79M0.97113,823 shs168,667 shs
iCAD, Inc. stock logo
ICAD
iCAD
$1.51
+3.4%
$1.62
$1.05
$3.97
$37.71M1.36110,757 shs78,054 shs
Iradimed Corporation stock logo
IRMD
Iradimed
$43.59
+2.1%
$42.76
$36.12
$51.04
$552.03M0.8645,451 shs29,293 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$2.51
+0.8%
$3.93
$1.03
$5.07
$112.40M2.583,660 shs197,466 shs
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$68.74
-1.0%
$68.96
$65.91
$100.59
$249.04M0.1525,173 shs12,259 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+2.00%+10.69%-4.23%-16.19%-36.49%
iCAD, Inc. stock logo
ICAD
iCAD
+1.39%-2.01%-18.89%+5.04%+5.80%
Iradimed Corporation stock logo
IRMD
Iradimed
-1.66%-2.62%+1.67%-1.48%-9.93%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-2.35%-28.86%-43.79%-30.83%-11.39%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
+0.67%+3.21%-2.17%-5.36%-27.32%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
1.4247 of 5 stars
3.51.00.00.03.20.00.6
iCAD, Inc. stock logo
ICAD
iCAD
0.7023 of 5 stars
2.05.00.00.01.00.80.0
Iradimed Corporation stock logo
IRMD
Iradimed
4.9889 of 5 stars
3.54.02.54.42.53.33.1
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.9818 of 5 stars
3.33.00.00.01.91.70.6
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
3.0187 of 5 stars
0.04.01.74.22.51.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$12.00104.78% Upside
iCAD, Inc. stock logo
ICAD
iCAD
N/AN/A$5.00231.13% Upside
Iradimed Corporation stock logo
IRMD
Iradimed
3.00
Buy$62.5043.38% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.50
Moderate Buy$8.00218.73% Upside
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/AN/AN/AN/A

Current Analyst Ratings

Latest ICAD, CLPT, IRMD, STIM, and UTMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
4/22/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$65.00
4/1/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Singular Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
3/26/2024
Neuronetics, Inc. stock logo
STIM
Neuronetics
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
3/13/2024
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00 ➝ $9.00
3/6/2024
Neuronetics, Inc. stock logo
STIM
Neuronetics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$7.00 ➝ $8.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$23.95M6.62N/AN/A$0.86 per share6.81
iCAD, Inc. stock logo
ICAD
iCAD
$17.32M2.30N/AN/A$1.27 per share1.19
Iradimed Corporation stock logo
IRMD
Iradimed
$65.56M8.42$1.42 per share30.61$6.01 per share7.25
Neuronetics, Inc. stock logo
STIM
Neuronetics
$71.35M1.05N/AN/A$1.18 per share2.13
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$50.22M4.91$6.28 per share10.95$35.35 per share1.94

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$22.09M-$0.91N/AN/AN/A-92.21%-83.94%-47.92%8/13/2024 (Estimated)
iCAD, Inc. stock logo
ICAD
iCAD
-$4.85M-$0.22N/AN/A-27.08%-21.63%-15.22%5/15/2024 (Confirmed)
Iradimed Corporation stock logo
IRMD
Iradimed
$17.19M$1.4130.9125.34N/A26.48%24.63%20.54%8/1/2024 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$30.19M-$1.07N/AN/AN/A-42.31%-72.76%-29.25%8/13/2024 (Estimated)
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$16.64M$4.5015.28N/A33.40%13.15%12.37%7/23/2024 (Estimated)

Latest ICAD, CLPT, IRMD, STIM, and UTMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2024N/A
iCAD, Inc. stock logo
ICAD
iCAD
N/AN/AN/AN/AN/AN/A  
3/12/2024Q4 2023
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.19+$0.03-$0.19$6.40 million$6.81 million
3/12/2024Q4 2023
iCAD, Inc. stock logo
ICAD
iCAD
N/A-$0.02-$0.02-$0.09N/A$4.74 million
3/5/202412/31/2023
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.26-$0.19+$0.07-$0.19$19.73 million$20.31 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
iCAD, Inc. stock logo
ICAD
iCAD
N/AN/AN/AN/AN/A
Iradimed Corporation stock logo
IRMD
Iradimed
$0.601.38%N/A42.55%N/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$1.201.75%+1.75%26.67%2 Years

Latest ICAD, CLPT, IRMD, STIM, and UTMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2024
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
Quarterly$0.301.75%6/14/20246/14/20247/5/2024
5/2/2024
Iradimed Corporation stock logo
IRMD
Iradimed
Quarterly$0.151.37%5/17/20245/20/20245/30/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.47
4.87
3.80
iCAD, Inc. stock logo
ICAD
iCAD
N/A
4.40
4.26
Iradimed Corporation stock logo
IRMD
Iradimed
N/A
9.44
7.77
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.73
4.73
4.33
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A
22.56
20.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
iCAD, Inc. stock logo
ICAD
iCAD
24.61%
Iradimed Corporation stock logo
IRMD
Iradimed
92.34%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
69.60%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.11%
iCAD, Inc. stock logo
ICAD
iCAD
11.95%
Iradimed Corporation stock logo
IRMD
Iradimed
42.60%
Neuronetics, Inc. stock logo
STIM
Neuronetics
9.80%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
6.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
10727.07 million25.42 millionOptionable
iCAD, Inc. stock logo
ICAD
iCAD
6726.37 million23.22 millionOptionable
Iradimed Corporation stock logo
IRMD
Iradimed
14812.66 million7.27 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
20329.98 million27.04 millionOptionable
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
1693.59 million3.35 millionNot Optionable

ICAD, CLPT, IRMD, STIM, and UTMD Headlines

SourceHeadline
Utah Medical Products, Inc. (NASDAQ:UTMD) to Issue Quarterly Dividend of $0.30Utah Medical Products, Inc. (NASDAQ:UTMD) to Issue Quarterly Dividend of $0.30
marketbeat.com - May 9 at 1:16 PM
Utah Medical Products, Inc. Announces Quarterly DividendUtah Medical Products, Inc. Announces Quarterly Dividend
accesswire.com - May 7 at 10:00 AM
Utah Medical Products (NASDAQ:UTMD) Share Price Passes Below 200 Day Moving Average of $76.50Utah Medical Products (NASDAQ:UTMD) Share Price Passes Below 200 Day Moving Average of $76.50
americanbankingnews.com - May 7 at 5:18 AM
Financial Contrast: Regenicin (OTCMKTS:RGIN) & Utah Medical Products (NASDAQ:UTMD)Financial Contrast: Regenicin (OTCMKTS:RGIN) & Utah Medical Products (NASDAQ:UTMD)
americanbankingnews.com - May 6 at 1:32 AM
Utah Medical Products First Quarter 2024 Earnings: EPS: US$1.09 (vs US$1.16 in 1Q 2023)Utah Medical Products First Quarter 2024 Earnings: EPS: US$1.09 (vs US$1.16 in 1Q 2023)
finance.yahoo.com - April 27 at 1:21 PM
The West has a veterinarian shortage. Can this new college bring animal health care to rural Utah?The West has a veterinarian shortage. Can this new college bring animal health care to rural Utah?
msn.com - April 27 at 8:20 AM
UTMD Stock Earnings: Utah Medical Products Reported Results for Q1 2024UTMD Stock Earnings: Utah Medical Products Reported Results for Q1 2024
investorplace.com - April 26 at 12:04 AM
Utah Medical Products EPS of $1.10, revenue of $11.3MUtah Medical Products EPS of $1.10, revenue of $11.3M
msn.com - April 25 at 5:08 PM
Utah Medical: Q1 Earnings SnapshotUtah Medical: Q1 Earnings Snapshot
washingtonpost.com - April 25 at 10:31 AM
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
accesswire.com - April 25 at 9:00 AM
Utah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-savingUtah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-saving'
msn.com - April 19 at 7:30 AM
Fairmat opens first U.S. industrial facility in UtahFairmat opens first U.S. industrial facility in Utah
compositesworld.com - April 18 at 3:57 PM
Hurdles in Utah push medical cannabis patients toward out-of-state products.Hurdles in Utah push medical cannabis patients toward out-of-state products.
cityweekly.net - April 17 at 6:18 PM
Advance directives help people plan for their future medical care and quality of lifeAdvance directives help people plan for their future medical care and quality of life
msn.com - April 12 at 5:30 PM
2 Beaten-Down Stocks That Could Be Ready to Soar2 Beaten-Down Stocks That Could Be Ready to Soar
fool.com - April 11 at 5:33 AM
Utah Department of Agriculture unveils new analysis of Utahs Medical Cannabis marketUtah Department of Agriculture unveils new analysis of Utah's Medical Cannabis market
cachevalleydaily.com - April 9 at 4:39 PM
Intermountain Health’s Transplant Program and patients celebrate life-saving medical milestoneIntermountain Health’s Transplant Program and patients celebrate life-saving medical milestone
msn.com - March 14 at 10:05 PM
Utah at the forefront of Americas alarming prescription drug shortagesUtah at the forefront of America's alarming prescription drug shortages
ksl.com - March 12 at 6:37 PM
Utah at the forefront of America’s alarming prescription drug shortagesUtah at the forefront of America’s alarming prescription drug shortages
msn.com - March 11 at 9:12 PM
Utah Valleys 1st osteopathic college to host grand opening for innovative buildingUtah Valley's 1st osteopathic college to host grand opening for 'innovative' building
ksl.com - March 4 at 2:15 PM
Utah Medical Products, Inc.s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Utah Medical Products, Inc.'s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - March 4 at 8:49 AM
Utah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiumsUtah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiums
msn.com - March 3 at 9:18 AM
Utah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outageUtah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outage
msn.com - February 25 at 2:35 PM
Utah affected by E. coli contamination in raw milk cheeseUtah affected by E. coli contamination in raw milk cheese
news.yahoo.com - February 18 at 2:20 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ClearPoint Neuro logo

ClearPoint Neuro

NASDAQ:CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
iCAD logo

iCAD

NASDAQ:ICAD
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Iradimed logo

Iradimed

NASDAQ:IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Neuronetics logo

Neuronetics

NASDAQ:STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Utah Medical Products logo

Utah Medical Products

NASDAQ:UTMD
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.